BioForce Nanosciences Holdings, Inc. (BFNH)
- Previous Close
0.5500 - Open
0.5480 - Bid 0.5000 x --
- Ask 0.5480 x 40000
- Day's Range
0.5480 - 0.5480 - 52 Week Range
0.1600 - 2.0700 - Volume
13 - Avg. Volume
584 - Market Cap (intraday)
18.37M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.
www.bioforceeclipse.com3
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BFNH
View MorePerformance Overview: BFNH
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BFNH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BFNH
View MoreValuation Measures
Market Cap
18.03M
Enterprise Value
18.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-4,268.96%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.29M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
13.8k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.79M